NCT01236443View on ClinicalTrials.gov

Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

May 31, 2003

Study Completion Date

April 30, 2013

Conditions
Barrett's EsophagusCISHigh Grade Dysplasia
Interventions
DRUG

HPPH

3 mg/m2 IV

Trial Locations (1)

14263

Roswell Park cancer institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT01236443 - Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus | Biotech Hunter | Biotech Hunter